Olympus Gets CMS Reimbursement Rates for New GI Procedure Codes
CMS has finalized 2027 reimbursement rates for new ESD procedure codes, a move Olympus says will expand U.S. patient access to organ-sparing GI care.
Olympus Corporation announced Wednesday that the Centers for Medicare & Medicaid Services has published final valuations and calendar year 2027 reimbursement rates for newly established CPT codes covering endoscopic submucosal dissection, a minimally invasive gastrointestinal procedure designed to remove tumors while preserving the affected organ.
The Tokyo- and Center Valley, Pennsylvania-based medical technology company said the finalized CMS rates mark a significant step toward standardizing payment for ESD in the United States, a procedure that has been widely adopted in parts of Asia and Europe but has faced reimbursement uncertainty in the American healthcare market.
Read more Fed Governor Waller Addresses Payments and Tokenized Markets Future →
Establishing dedicated CPT codes with defined reimbursement values is widely regarded in the medical device industry as a prerequisite for broad clinical adoption, as it removes financial ambiguity for hospital systems and gastroenterology practices weighing whether to invest in the training and equipment the procedure requires.
Olympus, which manufactures endoscopic systems used to perform ESD, positioned the CMS action as advancing patient access by giving providers a clearer economic pathway to offer the organ-sparing alternative to more invasive surgical resection for eligible GI patients.
The new rates are set to take effect for the 2027 calendar year, giving healthcare providers and payers time to incorporate the codes into contracting and billing workflows ahead of implementation. Continue reading at Banking & Financial Services.